Skip to the content
Please enable JavaScript in your browser to complete this form.
Evaluation Survey
1. The topics discussed in this meeting are relevant to my clinical practice
*
Strongly agree
Agree
Neural
Disagree
Strongly disagree
Strongly agree
Strongly agree
Agree
Agree
Neural
Neural
Disagree
Disagree
Strongly disagree
Strongly disagree
2. The webinar increased my understanding of the importance of early recognition and diagnosis of CLN2 disease
*
Strongly agree
Agree
Neural
Disagree
Strongly disagree
Strongly agree
Strongly agree
Agree
Agree
Neural
Neural
Disagree
Disagree
Strongly disagree
Strongly disagree
3. The webinar furthered my knowledge on using genetic testing to diagnose paediatric epilepsy
*
Strongly agree
Agree
Neural
Disagree
Strongly disagree
Strongly agree
Strongly agree
Agree
Agree
Neural
Neural
Disagree
Disagree
Strongly disagree
Strongly disagree
4. The date and time of the meeting were convenient to my schedule
*
Strongly agree
Agree
Neural
Disagree
Strongly disagree
Strongly agree
Strongly agree
Agree
Agree
Neural
Neural
Disagree
Disagree
Strongly disagree
Strongly disagree
5. The overall meeting was useful and interesting to me
*
Strongly agree
Agree
Neural
Disagree
Strongly disagree
Strongly agree
Strongly agree
Agree
Agree
Neural
Neural
Disagree
Disagree
Strongly disagree
Strongly disagree
6. Having joined the webinar, please select all statements that describe your confidence level in suspecting/screening CLN2 disease.
I feel confident recognising the early signs and symptoms of CLN2
I feel confident formulating a diagnostic pathway for patients with suspected CLN2
I feel confident identifying patients with suspected CLN2 who require referral for gene panel testing
7. Do you have any additional comments or suggestions? (optional)
APAC-CLN2-00094
Submit